Emphysema Market is driven by Increasing Smoking Prevalence
The emphysema market encompasses pharmaceutical agents, inhalation devices, and supportive therapies designed to manage chronic obstructive pulmonary disease (COPD) complications. Key products include bronchodilators such as long-acting beta-agonists (LABAs) and anticholinergics, inhaled corticosteroids (ICS), combination inhalers, and oxygen therapy systems. These interventions relieve...
0 Commentaires 0 Parts 109 Vue 0 Aperçu